Related Experiment Video
Updated: May 17, 2026
09:10
Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus
Piotr Szweda1, Marta Schielmann, Roman Kotlowski
1Department of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdańsk University of Technology, ul. G. Narutowicza 11/12, 80-233, Gdańsk, Poland. piotr.szweda@wp.pl
Applied Microbiology and Biotechnology
|October 19, 2012
Summary
Peptidoglycan hydrolases (PHs) show promise as novel therapeutics against antibiotic-resistant Staphylococcus infections. These enzymes rapidly kill bacteria and can enhance antibiotic effectiveness, offering a new strategy to combat challenging staphylococcal diseases.
Area of Science:
- Microbiology
- Biochemistry
- Drug Discovery
Background:
- Staphylococcus bacteria are significant causes of human and animal infections, including food poisoning.
- Increasing antibiotic resistance in staphylococci necessitates the development of alternative therapeutic strategies.
- Peptidoglycan hydrolases (PHs) are enzymes that degrade bacterial cell walls, leading to cell lysis.
Purpose of the Study:
- To review the current knowledge on peptidoglycan hydrolases (PHs) targeting staphylococci.
- To evaluate the potential of PHs as therapeutic agents against staphylococcal infections.
- To discuss challenges and opportunities in PH production and application.
Main Methods:
- Literature review focusing on peptidoglycan hydrolases and their activity against staphylococci.
- Analysis of enzyme specificity, including activity against Staphylococcus aureus and other staphylococcal species.
- Examination of PHs' role in combination therapy with antibiotics.
Main Results:
- PHs demonstrate potent bacteriolytic activity against staphylococci, including antibiotic-resistant strains.
- Some PHs exhibit broad specificity, lysing various staphylococcal species and other bacteria.
- PHs can potentiate the efficacy of conventional antibiotics, potentially reducing resistance development.
Conclusions:
- PHs represent a promising class of therapeutics for treating staphylococcal infections.
- Combined therapy with PHs and antibiotics may overcome existing resistance mechanisms.
- Further research is needed to optimize PH production for large-scale therapeutic applications.
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:28Peptidoglycan Synthesis
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:28Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...